An important difference from ROS1-positive non-small cell lung cancer is that patients newly diagnosed with low-grade and high-grade IDH mutant glioma live approximately 10 ... continues to play a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback